Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study

Harsányi AdriennDr. Tóth László ImreCsiha SáraMolnár ÁgnesDr. Lőrincz HajnalkaNagy Attila CsabaProf. Dr. Paragh GyörgyProf. Dr. Harangi MariannDr. Sztanek Ferenc2025-12-162025-12-162025-12https://hdl.handle.net/2437/400204Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study